TrialCancer2021

Assessment of pegylated arginine deiminase and modified FOLFOX6 in patients with advanced hepatocellular carcinoma: Results of an international, single-arm, phase 2 study.

James J Harding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.